527 related articles for article (PubMed ID: 34301348)
1. Low-molecular-weight heparin for prevention of preeclampsia and other placenta-mediated complications: a systematic review and meta-analysis.
Cruz-Lemini M; Vázquez JC; Ullmo J; Llurba E
Am J Obstet Gynecol; 2022 Feb; 226(2S):S1126-S1144.e17. PubMed ID: 34301348
[TBL] [Abstract][Full Text] [Related]
2. Does low-dose aspirin initiated before 11 weeks' gestation reduce the rate of preeclampsia?
Chaemsaithong P; Cuenca-Gomez D; Plana MN; Gil MM; Poon LC
Am J Obstet Gynecol; 2020 May; 222(5):437-450. PubMed ID: 31494125
[TBL] [Abstract][Full Text] [Related]
3. The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction.
Groom KM; David AL
Am J Obstet Gynecol; 2018 Feb; 218(2S):S829-S840. PubMed ID: 29229321
[TBL] [Abstract][Full Text] [Related]
4. Aspirin for prevention of preeclampsia and adverse perinatal outcome in twin pregnancies: a systematic review and meta-analysis.
D'Antonio F; Khalil A; Rizzo G; Fichera A; Herrera M; Buca D; Morelli R; Cerra C; Orabona R; Acuti Martellucci C; Flacco ME; Prefumo F
Am J Obstet Gynecol MFM; 2023 Feb; 5(2):100803. PubMed ID: 36402356
[TBL] [Abstract][Full Text] [Related]
5. Antiplatelet agents for preventing pre-eclampsia and its complications.
Duley L; Meher S; Hunter KE; Seidler AL; Askie LM
Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684684
[TBL] [Abstract][Full Text] [Related]
6. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis.
Roberge S; Nicolaides K; Demers S; Hyett J; Chaillet N; Bujold E
Am J Obstet Gynecol; 2017 Feb; 216(2):110-120.e6. PubMed ID: 27640943
[TBL] [Abstract][Full Text] [Related]
7. Low-molecular-weight heparin for the prevention of preeclampsia in high-risk pregnancies without thrombophilia: a systematic review and meta-analysis.
Chen J; Huai J; Yang H
BMC Pregnancy Childbirth; 2024 Jan; 24(1):68. PubMed ID: 38233773
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet therapy before or after 16 weeks' gestation for preventing preeclampsia: an individual participant data meta-analysis.
Meher S; Duley L; Hunter K; Askie L
Am J Obstet Gynecol; 2017 Feb; 216(2):121-128.e2. PubMed ID: 27810551
[TBL] [Abstract][Full Text] [Related]
9. Pravastatin is useful for prevention of recurrent severe placenta-mediated complications - a pilot study.
Kupferminc MJ; Kliger C; Rimon E; Asher-Landsberg J; Skornick-Rapaport A; Gamzu R; Yogev Y
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):8055-8061. PubMed ID: 34154497
[TBL] [Abstract][Full Text] [Related]
10. Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Hamulyák EN; Scheres LJ; Marijnen MC; Goddijn M; Middeldorp S
Cochrane Database Syst Rev; 2020 May; 5(5):CD012852. PubMed ID: 32358837
[TBL] [Abstract][Full Text] [Related]
11. Prevention of pre-eclampsia by low-molecular-weight heparin in addition to aspirin: a meta-analysis.
Roberge S; Demers S; Nicolaides KH; Bureau M; Côté S; Bujold E
Ultrasound Obstet Gynecol; 2016 May; 47(5):548-53. PubMed ID: 26481090
[TBL] [Abstract][Full Text] [Related]
12. Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a history: a randomized trial.
Groom KM; McCowan LM; Mackay LK; Lee AC; Said JM; Kane SC; Walker SP; van Mens TE; Hannan NJ; Tong S; Chamley LW; Stone PR; McLintock C;
Am J Obstet Gynecol; 2017 Mar; 216(3):296.e1-296.e14. PubMed ID: 28153659
[TBL] [Abstract][Full Text] [Related]
13. Combined Anticoagulant Therapy for Prevention of Preeclampsia and Small for Gestational Age Neonates: A Systematic Review and Meta-analysis.
Kontovazainitis CG; Gialamprinou D; Katsaras GN; Pouliakis A; Theodoridis T; Mitsiakos G
Am J Perinatol; 2023 Dec; 40(16):1745-1764. PubMed ID: 35235957
[TBL] [Abstract][Full Text] [Related]
14. Low-dose aspirin for the prevention of superimposed preeclampsia in women with chronic hypertension: a systematic review and meta-analysis.
Richards EMF; Giorgione V; Stevens O; Thilaganathan B
Am J Obstet Gynecol; 2023 Apr; 228(4):395-408. PubMed ID: 36209937
[TBL] [Abstract][Full Text] [Related]
15. Circulating maternal placental growth factor responses to low-molecular-weight heparin in pregnant patients at risk of placental dysfunction.
McLaughlin K; Hobson SR; Chandran AR; Agrawal S; Windrim RC; Parks WT; Bowman AW; Sovio U; Smith GC; Kingdom JC
Am J Obstet Gynecol; 2022 Feb; 226(2S):S1145-S1156.e1. PubMed ID: 34461078
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis on the effect of aspirin use for prevention of preeclampsia on placental abruption and antepartum hemorrhage.
Roberge S; Bujold E; Nicolaides KH
Am J Obstet Gynecol; 2018 May; 218(5):483-489. PubMed ID: 29305829
[TBL] [Abstract][Full Text] [Related]
17. Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta-analysis.
Bujold E; Morency AM; Roberge S; Lacasse Y; Forest JC; Giguère Y
J Obstet Gynaecol Can; 2009 Sep; 31(9):818-826. PubMed ID: 19941706
[TBL] [Abstract][Full Text] [Related]
18. Low-Dose Aspirin in Early Gestation for Prevention of Preeclampsia and Small-for-Gestational-Age Neonates: Meta-analysis of Large Randomized Trials.
Roberge S; Sibai B; McCaw-Binns A; Bujold E
Am J Perinatol; 2016 Jul; 33(8):781-5. PubMed ID: 26906184
[TBL] [Abstract][Full Text] [Related]
19. Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials.
Rodger MA; Gris JC; de Vries JIP; Martinelli I; Rey É; Schleussner E; Middeldorp S; Kaaja R; Langlois NJ; Ramsay T; Mallick R; Bates SM; Abheiden CNH; Perna A; Petroff D; de Jong P; van Hoorn ME; Bezemer PD; Mayhew AD;
Lancet; 2016 Nov; 388(10060):2629-2641. PubMed ID: 27720497
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
